CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Vinci Pharmaceuticals Inc. cierra una financiación de Serie A para impulsar EPIPLANT™

EPIPLANT™Positive
AI Analysis

Summary

Vinci Pharmaceuticals closed a Series A financing of over $8 million to advance its EPIPLANT™ drug delivery platform. Combined with a prior $8.5 million seed round, the company has raised over $16.5 million.

Importance:5/10
Sentiment:
0.70
Series A FinancingDrug Delivery PlatformCapital Raise

Read the original article

Published by PR Newswire Pharma on October 8, 2026 2:32 PM

Read Original